Super-Enhancer-Associated Hub Genes In Chronic Myeloid Leukemia Identified Using Weighted Gene Co-Expression Network Analysis

References

• Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell. 1984;36(1):93–99. doi:10.1016/0092-8674(84)90077-16319012
   PubMed Web of Science ®Google Scholar
• Daley GQ, Baltimore D. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. Proc Natl Acad Sci U S A. 1988;85(23):9312–9316. doi:10.1073/pnas.85.23.93123143116
   PubMed Web of Science ®Google Scholar
• Zhang J, Jiang Y, Han X, et al. Differential expression profiles and functional analysis of plasma miRNAs associated with chronic myeloid leukemia phases. Future Oncol. 2018;15(7):763–776.30501399
   PubMed Web of Science ®Google Scholar
• Arber DA, Orazi A. Update on the pathologic diagnosis of chronic myelomonocytic leukemia. Mod Pathol. 2019. doi:10.1038/s41379-019-0215-y
   Web of Science ®Google Scholar
• Heidari N, Abroun S, Bertacchini J, Vosoughi T, Rahim F, Saki N. Significance of inactivated genes in leukemia: pathogenesis and prognosis. Cell J. 2017;19(Suppl 1):9–26. doi:10.22074/cellj.2017.490828580304
   PubMedGoogle Scholar
• Druker BJ, Tamura S, Buchdunger E, et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med. 1996;2(5):561–566. doi:10.1038/nm0596-5618616716
   PubMed Web of Science ®Google Scholar
• Zhao WH, Huang BT, Zhang JY, Zeng QC. Distinct EphB4-mediated mechanisms of apoptotic and resistance to dasatinib in human chronic myeloid leukemia and K562 cell lines. Leuk Res. 2017;63:28–33. doi:10.1016/j.leukres.2017.10.01429096333
   PubMed Web of Science ®Google Scholar
• Xiao X, Jiang K, Xu Y, et al. (-)-Epigallocatechin-3-gallate induces cell apoptosis in chronic myeloid leukaemia by regulating Bcr/Abl-mediated p38-MAPK/JNK and JAK2/STAT3/AKT signalling pathways. Clin Exp Pharmacol Physiol. 2018;46(2):126–136.30251267
   PubMed Web of Science ®Google Scholar
• Corrado C, Saieva L, Raimondo S, Santoro A, De Leo G, Alessandro R. Chronic myelogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor. J Cell Mol Med. 2016;20(10):1829–1839. doi:10.1111/jcmm.1287327196940
   PubMed Web of Science ®Google Scholar
• Riva B, De Dominici M, Gnemmi I, et al. Celecoxib inhibits proliferation and survival of chronic myelogenous leukemia (CML) cells via AMPK-dependent regulation of beta-catenin and mTORC1/2. Oncotarget. 2016;7(49):81555–81570. doi:10.18632/oncotarget.1314627835591
   PubMedGoogle Scholar
• Lakkireddy S, Aula S, Kapley A, et al. Association of Vascular Endothelial Growth Factor A (VEGFA) and its receptor (VEGFR2) gene polymorphisms with risk of chronic myeloid leukemia and influence on clinical outcome. Mol Diagn Ther. 2016;20(1):33–44. doi:10.1007/s40291-015-0173-026476544
   PubMed Web of Science ®Google Scholar
• Weich N, Ferri C, Moiraghi B, et al. TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome. Blood Cells Mol Dis. 2016;59:129–133. doi:10.1016/j.bcmd.2016.05.00727282582
   PubMed Web of Science ®Google Scholar
• Liu W, Li L, Ye H, Tu W. [Weighted gene co-expression network analysis in biomedicine research]. Sheng Wu Gong Cheng Xue Bao. 2017;33(11):1791–1801. doi:10.13345/j.cjb.17000629202516
   PubMedGoogle Scholar
• Langfelder P, Horvath S. Eigengene networks for studying the relationships between co-expression modules. BMC Syst Biol. 2007;1:54. doi:10.1186/1752-0509-1-5418031580
   PubMed Web of Science ®Google Scholar
• Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559. doi:10.1186/1471-2105-9-55919114008
   PubMed Web of Science ®Google Scholar
• Shi T, Chen J, Li J, Yang BY, Zhang QL. Identification of key gene modules and pathways of human glioma through coexpression network. J Cell Physiol. 2019;234(2):1862–1870. doi:10.1002/jcp.2705930067869
   PubMed Web of Science ®Google Scholar
• Liu R, Zhang W, Liu ZQ, Zhou HH. Associating transcriptional modules with colon cancer survival through weighted gene co-expression network analysis. BMC Genomics. 2017;18(1):361. doi:10.1186/s12864-017-3761-z28486948
   PubMedGoogle Scholar
• Qiu JJ, Ren ZR, Yan JB. Identification and functional analysis of long non-coding RNAs in human and mouse early embryos based on single-cell transcriptome data. Oncotarget. 2016;7(38):61215–61228. doi:10.18632/oncotarget.1130427542205
   PubMedGoogle Scholar
• Luo Z, Liu R, Sun B, et al. Identification of gene modules associated with warfarin dosage by a genome-wide DNA methylation study. Pharmazie. 2018;73(5):288–293. doi:10.1691/ph.2018.731929724296
   PubMed Web of Science ®Google Scholar
• Alaei S, Sadeghi B, Najafi A, Masoudi-Nejad A. LncRNA and mRNA integration network reconstruction reveals novel key regulators in esophageal squamous-cell carcinoma. Genomics. 2019;111(1):76–89. doi:10.1016/j.ygeno.2018.01.00329317304
   PubMed Web of Science ®Google Scholar
• Liu S, Xie F, Xiang X, et al. Identification of differentially expressed genes, lncRNAs and miRNAs which are associated with tumor malignant phenotypes in hepatoblastoma patients. Oncotarget. 2017;8(57):97554–97564. doi:10.18632/oncotarget.2218129228631
   PubMedGoogle Scholar
• Shirasaki DI, Greiner ER, Al-Ramahi I, et al. Network organization of the huntingtin proteomic interactome in mammalian brain. Neuron. 2012;75(1):41–57. doi:10.1016/j.neuron.2012.05.02422794259
   PubMed Web of Science ®Google Scholar
• Pei G, Chen L, Zhang W. WGCNA application to proteomic and metabolomic data analysis. Methods Enzymol. 2017;585:135–158.28109426
   PubMed Web of Science ®Google Scholar
• Tong M, Li X, Wegener Parfrey L, et al. A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease. PLoS One. 2013;8(11):e80702. doi:10.1371/journal.pone.008070224260458
   PubMed Web of Science ®Google Scholar
• Chapuy B, McKeown MR, Lin CY, et al. Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma. Cancer Cell. 2013;24(6):777–790. doi:10.1016/j.ccr.2013.11.00324332044
   PubMed Web of Science ®Google Scholar
• Hnisz D, Abraham BJ, Lee TI, et al. Super-enhancers in the control of cell identity and disease. Cell. 2013;155(4):934–947. doi:10.1016/j.cell.2013.09.05324119843
   PubMed Web of Science ®Google Scholar
• Whyte WA, Orlando DA, Hnisz D, et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013;153(2):307–319. doi:10.1016/j.cell.2013.03.03523582322
   PubMed Web of Science ®Google Scholar
• Khan A, Zhang X. dbSUPER: a database of super-enhancers in mouse and human genome. Nucleic Acids Res. 2016;44(D1):D164–D171. doi:10.1093/nar/gkv100226438538
   PubMed Web of Science ®Google Scholar
• Langfelder P, Zhang B, Horvath S. Defining clusters from a hierarchical cluster tree: the dynamic tree cut package for R. Bioinformatics. 2008;24(5):719–720. doi:10.1093/bioinformatics/btm56318024473
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523. doi:10.1038/s41467-019-09234-630944313
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504. doi:10.1101/gr.123930314597658
   PubMed Web of Science ®Google Scholar
• Robinson JT, Thorvaldsdottir H, Winckler W, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29(1):24–26. doi:10.1038/nbt.175421221095
   PubMed Web of Science ®Google Scholar
• Wang X, Spandidos A, Wang H, Seed B. PrimerBank: a PCR primer database for quantitative gene expression analysis, 2012 update. Nucleic Acids Res. 2012;40(Database issue):D1144–D1149. doi:10.1093/nar/gkr101322086960
   PubMedGoogle Scholar
• Luo J, Qu J, Yang R, et al. Phytochemicals mediate the expression and activity of OCTN2 as activators of the PPARgamma/RXRalpha pathway. Front Pharmacol. 2016;7:189. doi:10.3389/fphar.2016.0018927445823
   PubMed Web of Science ®Google Scholar
• Ferreira AF, de Oliveira GL, Tognon R, et al. Apoptosis-related gene expression profile in chronic myeloid leukemia patients after imatinib mesylate and dasatinib therapy. Acta Haematol. 2015;133(4):354–364. doi:10.1159/00036944625721555
   PubMed Web of Science ®Google Scholar
• Ko JY, Oh S, Yoo KH. Functional enhancers as master regulators of tissue-specific gene regulation and cancer development. Mol Cells. 2017;40(3):169–177. doi:10.14348/molcells.2017.003328359147
   PubMed Web of Science ®Google Scholar
• Sengupta S, George RE. Super-enhancer-driven transcriptional dependencies in cancer. Trends Cancer. 2017;3(4):269–281. doi:10.1016/j.trecan.2017.03.00628718439
   PubMed Web of Science ®Google Scholar
• Thandapani P. Super-enhancers in cancer. Pharmacol Ther. 2019. doi:10.1016/j.pharmthera.2019.02.014
   PubMed Web of Science ®Google Scholar
• Huang J, Li K, Cai W, et al. Dissecting super-enhancer hierarchy based on chromatin interactions. Nat Commun. 2018;9(1):943. doi:10.1038/s41467-018-03279-929507293
   PubMedGoogle Scholar
• Rodriguez-Rodriguez JA, Lewis C, McKinley KL, et al. Distinct roles of RZZ and Bub1-KNL1 in mitotic checkpoint signaling and kinetochore expansion. Curr Biol. 2018;28(21):3422.e3425–3429.e3425. doi:10.1016/j.cub.2018.10.006
   PubMed Web of Science ®Google Scholar
• Mur P, De Voer RM, Olivera-Salguero R, et al. Germline mutations in the spindle assembly checkpoint genes BUB1 and BUB3 are infrequent in familial colorectal cancer and polyposis. Mol Cancer. 2018;17(1):23. doi:10.1186/s12943-018-0762-829448935
   PubMedGoogle Scholar
• de Voer RM, Geurts van Kessel A, Weren RD, et al. Germline mutations in the spindle assembly checkpoint genes BUB1 and BUB3 are risk factors for colorectal cancer. Gastroenterology. 2013;145(3):544–547. doi:10.1053/j.gastro.2013.06.00123747338
   PubMed Web of Science ®Google Scholar
• Zhang L, Huang Y, Ling J, et al. Screening and function analysis of hub genes and pathways in hepatocellular carcinoma via bioinformatics approaches. Cancer Biomark. 2018;22(3):511–521. doi:10.3233/CBM-17116029843214
   PubMed Web of Science ®Google Scholar
• Siemeister G, Mengel A, Fernandez-Montalvan AE, et al. Inhibition of BUB1 kinase by BAY 1816032 sensitizes tumor cells toward taxanes, ATR, and PARP inhibitors in vitro and in vivo. Clin Cancer Res. 2018;5(4):1404–1414.
   Google Scholar
• Ritter A, Kreis NN, Louwen F, Wordeman L, Yuan J. Molecular insight into the regulation and function of MCAK. Crit Rev Biochem Mol Biol. 2015;51(4):228–245. doi:10.1080/10409238.2016.117870527146484
   PubMed Web of Science ®Google Scholar
• Bie L, Zhao G, Wang YP, Zhang B. Kinesin family member 2C (KIF2C/MCAK) is a novel marker for prognosis in human gliomas. Clin Neurol Neurosurg. 2012;114(4):356–360.22130050
   PubMed Web of Science ®Google Scholar
• Gu Y, Lu L, Wu L, Chen H, Zhu W, He Y. Identification of prognostic genes in kidney renal clear cell carcinoma by RNAseq data analysis. Mol Med Rep. 2017;15(4):1661–1667. doi:10.3892/mmr.2017.619428260099
   PubMed Web of Science ®Google Scholar
• Duan H, Zhang X, Wang FX, et al. KIF-2C expression is correlated with poor prognosis of operable esophageal squamous cell carcinoma male patients. Oncotarget. 2016;7(49):80493–80507. doi:10.18632/oncotarget.1149227563815
   PubMedGoogle Scholar
• Rasmussen RD, Gajjar MK, Tuckova L, et al. BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicity. Nat Commun. 2016;7:13398. doi:10.1038/ncomms1339827845331
   PubMed Web of Science ®Google Scholar
• Luo X, Yu H, Song Y, Sun T. Integration of metabolomic and transcriptomic data reveals metabolic pathway alteration in breast cancer and impact of related signature on survival. J Cell Physiol. 2018;34(8):13021–13031.
   Google Scholar
• Liang WH, Li N, Yuan ZQ, Qian XL, Wang ZH. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2. Mol Carcinog. 2018;58(4):461–473.30457164
   PubMed Web of Science ®Google Scholar
• Liu R, Guo CX, Zhou HH. Network-based approach to identify prognostic biomarkers for estrogen receptor-positive breast cancer treatment with tamoxifen. Cancer Biol Ther. 2015;16(2):317–324. doi:10.1080/15384047.2014.100236025756514
   PubMed Web of Science ®Google Scholar
• Liu R, Lv QL, Yu J, et al. Correlating transcriptional networks with pathological complete response following neoadjuvant chemotherapy for breast cancer. Breast Cancer Res Treat. 2015;151(3):607–618. doi:10.1007/s10549-015-3428-x25981901
   PubMed Web of Science ®Google Scholar
• He Z, Tang F, Lu Z, et al. Analysis of differentially expressed genes, clinical value and biological pathways in prostate cancer. Am J Transl Res. 2018;10(5):1444–1456.29887958
   PubMed Web of Science ®Google Scholar
• Li J, Pang J, Liu Y, et al. Suppression of RRM2 inhibits cell proliferation, causes cell cycle arrest and promotes the apoptosis of human neuroblastoma cells and in human neuroblastoma RRM2 is suppressed following chemotherapy. Oncol Rep. 2018;40(1):355–360. doi:10.3892/or.2018.642029749541
   PubMed Web of Science ®Google Scholar
• Chang CC, Lin CC, Wang CH, et al. miR-211 regulates the expression of RRM2 in tumoral metastasis and recurrence in colorectal cancer patients with a k-ras gene mutation. Oncol Lett. 2018;15(5):8107–8117. doi:10.3892/ol.2018.829529731918
   PubMed Web of Science ®Google Scholar
• Farrell JJ, Moughan J, Wong JL, et al. Precision medicine and pancreatic cancer: a gemcitabine pathway approach. Pancreas. 2016;45(10):1485–1493. doi:10.1097/MPA.000000000000071027748721
   PubMed Web of Science ®Google Scholar
• He B, Yin J, Gong S, et al. Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis. Medicine (Baltimore). 2017;96(25):e6938. doi:10.1097/MD.000000000000693828640074
   PubMed Web of Science ®Google Scholar
• Zhang C, Peng L, Zhang Y, et al. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data. Med Oncol. 2017;34(6):101. doi:10.1007/s12032-017-0963-928432618
   PubMed Web of Science ®Google Scholar
• Grolmusz VK, Karaszi K, Micsik T, et al. Cell cycle dependent RRM2 may serve as proliferation marker and pharmaceutical target in adrenocortical cancer. Am J Cancer Res. 2016;6(9):2041–2053.27725909
   PubMed Web of Science ®Google Scholar
• Zheng S, Wang X, Weng YH, et al. siRNA knockdown of RRM2 effectively suppressed pancreatic tumor growth alone or synergistically with doxorubicin. Mol Ther Nucleic Acids. 2018;12:805–816. doi:10.1016/j.omtn.2018.08.00330153565
   PubMedGoogle Scholar
• Wu Y, Sun J, Li A, Chen D. The promoted delivery of RRM2 siRNA to vascular smooth muscle cells through liposome-polycation-DNA complex conjugated with cell penetrating peptides. Biomed Pharmacother. 2018;103:982–988. doi:10.1016/j.biopha.2018.03.06829710515
   PubMed Web of Science ®Google Scholar
• Chen CW, Li Y, Hu S, et al. DHS (trans-4,4ʹ-dihydroxystilbene) suppresses DNA replication and tumor growth by inhibiting RRM2 (ribonucleotide reductase regulatory subunit M2). Oncogene. 2018;38(13):2364–2379.30518875
   PubMed Web of Science ®Google Scholar
• Fernandez-Cid A, Riera A, Tognetti S, et al. An ORC/Cdc6/MCM2-7 complex is formed in a multistep reaction to serve as a platform for MCM double-hexamer assembly. Mol Cell. 2013;50(4):577–588. doi:10.1016/j.molcel.2013.03.02623603117
   PubMed Web of Science ®Google Scholar
• Diaz-Trivino S, Del Mar Castellano M, de la Paz Sanchez M, Ramirez-Parra E, Desvoyes B, Gutierrez C. The genes encoding arabidopsis ORC subunits are E2F targets and the two ORC1 genes are differently expressed in proliferating and endoreplicating cells. Nucleic Acids Res. 2005;33(17):5404–5414. doi:10.1093/nar/gki85416179646
   PubMed Web of Science ®Google Scholar
• Asano M, Wharton RP. E2F mediates developmental and cell cycle regulation of ORC1 in Drosophila. Embo J. 1999;18(9):2435–2448. doi:10.1093/emboj/18.9.243510228158
   PubMed Web of Science ®Google Scholar
• Chen X, Xiong D, Ye L, et al. Up-regulated lncRNA XIST contributes to progression of cervical cancer via regulating miR-140-5p and ORC1. Cancer Cell Int. 2019;19:45. doi:10.1186/s12935-019-0744-y30858762
   PubMed Web of Science ®Google Scholar
• Saito A, Muro Y, Sugiura K, Ikeno M, Yoda K, Tomita Y. CENP-O, a protein localized at the centromere throughout the cell cycle, is a novel target antigen in systemic sclerosis. J Rheumatol. 2009;36(4):781–786. doi:10.3899/jrheum.08072619286853
   PubMed Web of Science ®Google Scholar